Prelude Therapeutics Inc
(NAS:PRLD)
$
4.99
+0.080 (+1.63%)
Market Cap: 397.43 Mil
Enterprise Value: 333.60 Mil
PE Ratio: 0
PB Ratio: 5.20
GF Score: 26/100 Prelude Therapeutics Inc (PRLD) Transcripts
- 1